Chen D, Curtis J, Chen Y
Chin Med J Pulm Crit Care Med. 2024; 1(2):84-93.
PMID: 39170827
PMC: 11332824.
DOI: 10.1016/j.pccm.2023.03.004.
Garcia Morales O, Canas-Arboleda A, Rodriguez Malagon M, Galindo Pedraza J, Rodriguez Torres P, Avendano Morales V
Front Med (Lausanne). 2024; 11:1321371.
PMID: 38803343
PMC: 11128574.
DOI: 10.3389/fmed.2024.1321371.
Kayongo A, Nyiro B, Siddharthan T, Kirenga B, Checkley W, Joloba M
Front Cell Infect Microbiol. 2023; 13:1146571.
PMID: 37415827
PMC: 10320222.
DOI: 10.3389/fcimb.2023.1146571.
Lu Z, Coll P, Maitre B, Epaud R, Lanone S
Eur Respir Rev. 2022; 31(165).
PMID: 35948393
PMC: 9724895.
DOI: 10.1183/16000617.0059-2022.
Celli B, Fabbri L, Criner G, Martinez F, Mannino D, Vogelmeier C
Am J Respir Crit Care Med. 2022; 206(11):1317-1325.
PMID: 35914087
PMC: 9746870.
DOI: 10.1164/rccm.202204-0671PP.
Role of Short-Chain Fatty Acids Produced by Gut Microbiota in Innate Lung Immunity and Pathogenesis of the Heterogeneous Course of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci. 2022; 23(9).
PMID: 35563159
PMC: 9099629.
DOI: 10.3390/ijms23094768.
Pathogenesis of chronic obstructive pulmonary disease: understanding the contributions of gene-environment interactions across the lifespan.
Agusti A, Melen E, DeMeo D, Breyer-Kohansal R, Faner R
Lancet Respir Med. 2022; 10(5):512-524.
PMID: 35427533
PMC: 11428195.
DOI: 10.1016/S2213-2600(21)00555-5.
Disease Trajectories and Impact of One Moderate Exacerbation in Gold B COPD Patients.
Lokke A, Hilberg O, Lange P, Ibsen R, Stratelis G, de Fine Licht S
Int J Chron Obstruct Pulmon Dis. 2022; 17:569-578.
PMID: 35321533
PMC: 8937604.
DOI: 10.2147/COPD.S344669.
Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) Comorbidities in Lithuanian National Database: A Cluster Analysis.
Jureviciene E, Burneikaite G, Dambrauskas L, Kasiulevicius V, Kazenaite E, Navickas R
Int J Environ Res Public Health. 2022; 19(2).
PMID: 35055792
PMC: 8775709.
DOI: 10.3390/ijerph19020970.
Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study.
Nieri D, Daniele M, Lombardi S, Bazzan E, Santerini S, De Cusatis G
J Clin Med. 2021; 10(21).
PMID: 34768536
PMC: 8584816.
DOI: 10.3390/jcm10215014.
COPD Diagnosis: Time for Disruption.
Wouters E, Breyer M, Breyer-Kohansal R, Hartl S
J Clin Med. 2021; 10(20).
PMID: 34682780
PMC: 8539379.
DOI: 10.3390/jcm10204660.
Inflammatory parameters and pulmonary biomarkers in smokers with and without chronic obstructive pulmonary disease (COPD).
Andreeva E, Pokhasnikova M, Lebedev A, Moiseeva I, Kozlov A, Kuznetsova O
J Thorac Dis. 2021; 13(8):4812-4829.
PMID: 34527321
PMC: 8411144.
DOI: 10.21037/jtd-20-1580.
10-Year Follow-Up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study.
Ragland M, Strand M, Baraghoshi D, Young K, Kinney G, Austin E
Ann Am Thorac Soc. 2021; 19(3):381-388.
PMID: 34461026
PMC: 8937219.
DOI: 10.1513/AnnalsATS.202007-873OC.
The "Slow Horse Racing Effect" on Lung Function in Adult Life in Chronic Obstructive Pulmonary Disease Associated to Biomass Exposure.
Ramirez-Venegas A, Montiel-Lopez F, Falfan-Valencia R, Perez-Rubio G, Sansores R
Front Med (Lausanne). 2021; 8:700836.
PMID: 34307427
PMC: 8295605.
DOI: 10.3389/fmed.2021.700836.
Early chronic obstructive pulmonary disease: A new perspective.
Lu H, Zeng H, Chen Y
Chronic Dis Transl Med. 2021; 7(2):79-87.
PMID: 34136767
PMC: 8180470.
DOI: 10.1016/j.cdtm.2021.02.003.
Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease.
Kotlyarov S
Int J Mol Sci. 2021; 22(7).
PMID: 33805156
PMC: 8037621.
DOI: 10.3390/ijms22073334.
Early COPD: current evidence for diagnosis and management.
Fazleen A, Wilkinson T
Ther Adv Respir Dis. 2020; 14:1753466620942128.
PMID: 32664818
PMC: 7394029.
DOI: 10.1177/1753466620942128.
Health-related quality of life associates with change in FEV in COPD: results from the COSYCONET cohort.
Lutter J, Jorres R, Kahnert K, Schwarzkopf L, Studnicka M, Karrasch S
BMC Pulm Med. 2020; 20(1):148.
PMID: 32471493
PMC: 7257512.
DOI: 10.1186/s12890-020-1147-5.
Review of Drug Development Guidance to Treat Chronic Obstructive Pulmonary Disease: US and EU Perspectives.
van Haarst A, McGarvey L, Paglialunga S
Clin Pharmacol Ther. 2019; 106(6):1222-1235.
PMID: 31334840
PMC: 6896238.
DOI: 10.1002/cpt.1540.
Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment.
Celli B, Navaie M, Xu Z, Cho-Reyes S, Dembek C, Gilmer T
Int J Chron Obstruct Pulmon Dis. 2019; 14:1019-1031.
PMID: 31190787
PMC: 6526678.
DOI: 10.2147/COPD.S199251.